Cargando…

Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait

This report describes the modification of hemiplegic shoulder pain and walking velocity through injections of Xeomin®, a new botulinum neurotoxin type A formulation, in a 67-year-old woman with chronic residual left hemiparesis and hemiparetic gait attributable to stroke. Clinical evaluation include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falso, Maurizio, Galluso, Rosalba, Malvicini, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490473/ https://www.ncbi.nlm.nih.gov/pubmed/23139852 http://dx.doi.org/10.4081/ni.2012.e8

Ejemplares similares

Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012)

Xeomin(®), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
por: Mastrorilli, Valentina, et al.
Publicado: (2023)

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
por: Jimenez-Shahed, Joohi
Publicado: (2012)

Designing Ecological Auditory Feedback on Lower Limb Kinematics for Hemiparetic Gait Training
por: Kantan, Prithvi Ravi, et al.
Publicado: (2023)

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2022)

Shared and distinct voxel-based lesion-symptom mappings for spasticity and impaired movement in the hemiparetic upper limb
por: Frenkel-Toledo, Silvi, et al.
Publicado: (2022)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013)

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Comprehensive evaluation of gait, spasticity, and muscle morphology: A case report of a child with spastic paresis treated with Botulinum NeuroToxin‐A, serial casting, and physiotherapy
por: Weide, Guido, et al.
Publicado: (2019)

Lesion location impact on functional recovery of the hemiparetic upper limb
por: Frenkel-Toledo, Silvi, et al.
Publicado: (2019)

Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity
por: Ghroubi, Sameh, et al.
Publicado: (2020)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor
por: Kreisler, Alexandre, et al.
Publicado: (2019)

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
por: Abogunrin, Seye, et al.
Publicado: (2015)

Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
por: Veverka, Tomáš, et al.
Publicado: (2019)

Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia
por: Trompetto, Carlo, et al.
Publicado: (2022)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN(®)) Botulinum Toxin in Chronic Refractory Migraine
por: Ion, Ioana, et al.
Publicado: (2018)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
por: Lagnau, Philippe, et al.
Publicado: (2021)

Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity
por: Vinehout, Kaleb, et al.
Publicado: (2021)

Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
por: Shackley, Phil, et al.
Publicado: (2012)

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
por: Marvulli, Riccardo, et al.
Publicado: (2019)

Shear Wave Velocity to Evaluate the Effect of Botulinum Toxin on Post-Stroke Spasticity of the Lower Limb
por: Hasegawa, Yuki, et al.
Publicado: (2022)

Efficacy on gait and posture control after botulinum toxin A injection for lower-limb spasticity treatment after stroke: A randomized controlled trial
por: Yu, Hui-xian, et al.
Publicado: (2023)

When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
por: Gracies, Jean-Michel, et al.
Publicado: (2020)

Changes in Lower Limb Muscle Activation and Degree of Weight Support according to Types of Cane-Supported Gait in Hemiparetic Stroke Patients
por: Choi, Eun Pyeong, et al.
Publicado: (2020)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Effects of 4 weeks of dynamic neuromuscular stabilization training on balance and gait performance in an adolescent with spastic hemiparetic cerebral palsy
por: Kim, Do-Hyun, et al.
Publicado: (2017)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting
por: Jacinto, Jorge, et al.
Publicado: (2022)

Intramuscular Neural Distribution of Adductor Pollicis Muscle Spasticity in Cadaver Model Regarding Botulinum Neurotoxin Treatment
por: Yi, Kyu-Ho, et al.
Publicado: (2023)

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Benefits of Repetitive Transcranial Magnetic Stimulation (rTMS) for Spastic Subjects: Clinical, Functional, and Biomechanical Parameters for Lower Limb and Walking in Five Hemiparetic Patients
por: Terreaux, Luc, et al.
Publicado: (2014)

The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy
por: Choi, Ja Young, et al.
Publicado: (2019)

Pelvis-Toe Distance: 3-Dimensional Gait Characteristics of Functional Limb Shortening in Hemiparetic Stroke
por: Haruyama, Koshiro, et al.
Publicado: (2021)

Passive Properties of the Wrist and Fingers Following Chronic Hemiparetic Stroke: Interlimb Comparisons in Persons With and Without a Clinical Treatment History That Includes Botulinum Neurotoxin
por: Binder-Markey, Benjamin I., et al.
Publicado: (2021)

Transcranial direct current stimulation combined with upper limb functional training in children with spastic, hemiparetic cerebral palsy: study protocol for a randomized controlled trial
por: Moura, Renata Calhes Franco, et al.
Publicado: (2016)

Feasibility of Video Clip Analysis on Effect of Botulinum Toxin-A Injection for Post-Stroke Upper Limb Spasticity
por: Kim, Woo-Jin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rf426d0bqaneqgrjgkmia6sev1